We are a young group that aims to bring the latest engineering and genomics technologies at the forefront of cardiac pathobiology
Our philosophy is to develop innovative approaches to manipulate gene, cell, and tissue function, and to apply these advancements to provide a fresh take on key open questions in chromatin biology, heart development, and heart disease
We also like to explore how our work can impact other fields (et al.), particularly climate change mitigation through cellular agriculture
We are currently moving from the University of Washington
to the Molecular Biotechnology Center of the University of Turin in Italy